首页 > 最新文献

中华泌尿外科杂志最新文献

英文 中文
A case report of large cell undifferentiated carcinoma of the urinary bladder 膀胱大细胞未分化癌1例报告
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.013
Huafeng Zhang, Jia Zhao, L. Xia, Shang-Wen Yang, Xuezhong Chen
The clinical pathological data of a patient large cell undifferentiated bladder carcinoma was retrospectively analyzed and understand. The clinical and imaging findings of large cell undifferentiated bladder carcinoma was nonspecific. Diagnosis depended on the pathological and immuno-histochemical staining. The tumor is aggressive with high risk of recurrence.It is mainly treated with radical resection. Key words: Urinary bladder; Undifferentiated carcinoma; Large cell carcinoma
对一例大细胞未分化膀胱癌的临床病理资料进行回顾性分析和了解。大细胞未分化膀胱癌的临床和影像学表现是非特异性的。诊断依赖于病理和免疫组织化学染色。肿瘤具有侵袭性,复发风险高。主要采用根治性切除术治疗。关键词:膀胱;未分化癌;大细胞癌
{"title":"A case report of large cell undifferentiated carcinoma of the urinary bladder","authors":"Huafeng Zhang, Jia Zhao, L. Xia, Shang-Wen Yang, Xuezhong Chen","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.013","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.013","url":null,"abstract":"The clinical pathological data of a patient large cell undifferentiated bladder carcinoma was retrospectively analyzed and understand. The clinical and imaging findings of large cell undifferentiated bladder carcinoma was nonspecific. Diagnosis depended on the pathological and immuno-histochemical staining. The tumor is aggressive with high risk of recurrence.It is mainly treated with radical resection. \u0000 \u0000Key words: \u0000Urinary bladder; Undifferentiated carcinoma; Large cell carcinoma","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43258490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two cases report of treatment of renal parapelvic cysts with incision and drainage by flexible ureteroscope combined with the All-Seeing needle 输尿管软镜联合全视针切开引流治疗肾盆腔旁囊肿2例报告
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.014
Ting Huang, Li Fang, Yue Cheng
Flexible ureteroscopic incision and drainage is an innovative surgical option for renal parapelvic cysts these years. Finding the thinnest part of the renal parapelvic cyst is the key point of the surgery. This paper reports two patients with renal parapelvic cysts treated with flexible ureteroscopic incision and drainage combined with All-Seeing needle. The operations were successful and had good outcomes with the two-year follow-up. Key words: Kidney disease, cystic; Peripelvic cyst; Flexible ureterscope; All-Seeing needle
近年来,柔性输尿管镜切开引流是治疗肾盂旁囊肿的一种创新手术选择。找到肾盂旁囊肿最薄的部位是手术的关键。本文报告两例肾盂旁囊肿患者,均采用弹性输尿管镜切开引流结合万灵针治疗。手术取得了成功,并在两年的随访中取得了良好的结果。关键词:肾脏疾病,囊性;盆腔周围囊肿;柔性输尿管镜;万能针
{"title":"Two cases report of treatment of renal parapelvic cysts with incision and drainage by flexible ureteroscope combined with the All-Seeing needle","authors":"Ting Huang, Li Fang, Yue Cheng","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.014","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.014","url":null,"abstract":"Flexible ureteroscopic incision and drainage is an innovative surgical option for renal parapelvic cysts these years. Finding the thinnest part of the renal parapelvic cyst is the key point of the surgery. This paper reports two patients with renal parapelvic cysts treated with flexible ureteroscopic incision and drainage combined with All-Seeing needle. The operations were successful and had good outcomes with the two-year follow-up. \u0000 \u0000Key words: \u0000Kidney disease, cystic; Peripelvic cyst; Flexible ureterscope; All-Seeing needle","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42688327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The feasibility and efficacy of total laparoscopic radical cystectomy with intracorporeal Xing's orthotopic neobladder 腹腔镜膀胱根治术加原位新膀胱的可行性和疗效
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.003
Liyuan Wu, Fei-ya Yang, L. Mou, Qinxin Zhao, Hongjiang Song, Xuesong Li, Qian Zhang, B. Shi, N. Xing
Objective To explore the feasibility and clinical effect of laparoscopic radical cystectomy with intracorporeal Xing's orthotopic neobladder. Methods Forty-one patients who underwent laparoscopic radical cystectomy with intracorporeal Xing's orthotopic neobladder from July 2013 to August 2019. There were 31 cases performed in Beijing Chaoyang hospital and 10 cases in National Cancer Center. Mean age was 59(range 44-78) years, mean BMI was 25.3(range 20.1-34.7)kg/m2 , and mean CCI was 3 (range 2-6). No urethral stricture or urinary incontinence was found by preoperative examination. No distant metastasis was identified by bone scans, chest X-ray and sonography. Cystoscopy or TURBT was performed on all patients and biopsy was taken to confirm the diagnosis. Preoperative pathology showed 30 cases (73.2%) of MIBC, 9 cases of NMIBC (22.0%) and 2 cases (4.9%) of in-situ cancer. Laparoscopic radical cystectomy and lymphadenectomy were performed under general anesthesia. Urinary diversion was completed in the peritoneal cavity, by intercepting the terminal ileum about 60 cm, and taking the proximal ileum 10 cm as input loop on the right side with proximal to distal way, and the middle 40 cm ileum was detubated. After u-shaped suture, the ileum was folded back and stitched into a sphere building a novel orthotopic neobladder with bilateral isoperistaltic afferent limbs. The prognosis of perioperative data and postoperative satisfaction regarding continence were analyzed, continence was defined as 0-1 pad/day. The 41 patients were divided into two groups to compare the difference in term of operation time and blood loss between the first 21 patients and the last 20 patients. Results Mean total operative time was 324.9 mins (range 210-480) mins, and mean estimated blood loss was 177.6(range 50-700) ml. There were significant statistical differences in term of total operation time, construction time and blood loss between the first 21 patients and the next 20 patients (P<0.05). Postoperative pathological results were urothelial carcinoma in 40 cases (2 in situ carcinoma) and small cell carcinoma in 1 case. Mean number of dissected lymph nodes was 19 (range 11-58), with 7 cases(17.1%)of positive lymph nodes, and 3 cases(7.3%)had positive surgical margin. At a mean follow up of 17.6(range 2-64) months, 36 patients (87.8%) survived, including 2 patients (4.9%) with metastasis and 1 patient (2.4%) with recurrence, and 5 cases (12.2%)died. All patients were able to urinate without catheterization. Thirty-seven patients (90.2%) were satisfied with voiding control during the daytime (0-1 urinal pad), and 29 patients (70.7%) were satisfied with voiding control at nighttime (0-1 urinal pad) by the follow-up 12 months after the operation. Conclusions Total laparoscopic radical cystectomy combined with Xing's orthotopic ileum neobladder is a simple method with fewer postoperative complications and a satisfactory continence rate. Key words: Urin
目的探讨腹腔镜下邢氏原位新膀胱根治术的可行性及临床效果。方法2013年7月至2019年8月对41例患者行腹腔镜根治性膀胱切除术。北京朝阳医院31例,国家肿瘤中心10例。平均年龄59岁(44 ~ 78岁),平均BMI为25.3(20.1 ~ 34.7)kg/m2,平均CCI为3(2 ~ 6)。术前检查未发现尿道狭窄或尿失禁。骨扫描、胸部x线及超声检查未发现远处转移。所有患者均行膀胱镜检查或TURBT检查,并行活检以确认诊断。术前病理显示:MIBC 30例(73.2%),NMIBC 9例(22.0%),原位癌2例(4.9%)。全麻下行腹腔镜根治性膀胱切除术和淋巴结切除术。在腹腔内完成导尿,截留末端回肠约60 cm,以近端至远端回肠10 cm为右侧输入袢,中间40 cm回肠引管。u形缝合后,回肠折回缝合成一个球体,建立一个具有双侧等径传入肢的新型原位新膀胱。分析围手术期预后资料及术后尿失禁满意度,尿失禁定义为0-1尿/天。将41例患者分为两组,比较前21例患者与后20例患者在手术时间和出血量方面的差异。结果平均总手术时间324.9 min(范围210 ~ 480)min,平均预估失血量177.6 ml(范围50 ~ 700)ml。前21例患者与后20例患者在总手术时间、构建时间及失血量方面差异有统计学意义(P<0.05)。术后病理结果:尿路上皮癌40例(原位癌2例),小细胞癌1例。平均淋巴结清扫数19例(范围11 ~ 58),阳性淋巴结7例(17.1%),切缘阳性3例(7.3%)。平均随访17.6个月(2 ~ 64个月),36例(87.8%)患者存活,其中转移2例(4.9%),复发1例(2.4%),死亡5例(12.2%)。所有患者无需导尿即可正常排尿。术后12个月随访,37例(90.2%)患者对白天(0-1块尿垫)排尿控制满意,29例(70.7%)患者对夜间(0-1块尿垫)排尿控制满意。结论腹腔镜全膀胱根治术联合邢氏原位回肠新膀胱手术方法简单,术后并发症少,尿失禁率满意。关键词:膀胱肿瘤;完全镜头辅助;邢氏原位新膀胱;尿转移
{"title":"The feasibility and efficacy of total laparoscopic radical cystectomy with intracorporeal Xing's orthotopic neobladder","authors":"Liyuan Wu, Fei-ya Yang, L. Mou, Qinxin Zhao, Hongjiang Song, Xuesong Li, Qian Zhang, B. Shi, N. Xing","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.003","url":null,"abstract":"Objective \u0000To explore the feasibility and clinical effect of laparoscopic radical cystectomy with intracorporeal Xing's orthotopic neobladder. \u0000 \u0000 \u0000Methods \u0000Forty-one patients who underwent laparoscopic radical cystectomy with intracorporeal Xing's orthotopic neobladder from July 2013 to August 2019. There were 31 cases performed in Beijing Chaoyang hospital and 10 cases in National Cancer Center. Mean age was 59(range 44-78) years, mean BMI was 25.3(range 20.1-34.7)kg/m2 , and mean CCI was 3 (range 2-6). No urethral stricture or urinary incontinence was found by preoperative examination. No distant metastasis was identified by bone scans, chest X-ray and sonography. Cystoscopy or TURBT was performed on all patients and biopsy was taken to confirm the diagnosis. Preoperative pathology showed 30 cases (73.2%) of MIBC, 9 cases of NMIBC (22.0%) and 2 cases (4.9%) of in-situ cancer. Laparoscopic radical cystectomy and lymphadenectomy were performed under general anesthesia. Urinary diversion was completed in the peritoneal cavity, by intercepting the terminal ileum about 60 cm, and taking the proximal ileum 10 cm as input loop on the right side with proximal to distal way, and the middle 40 cm ileum was detubated. After u-shaped suture, the ileum was folded back and stitched into a sphere building a novel orthotopic neobladder with bilateral isoperistaltic afferent limbs. The prognosis of perioperative data and postoperative satisfaction regarding continence were analyzed, continence was defined as 0-1 pad/day. The 41 patients were divided into two groups to compare the difference in term of operation time and blood loss between the first 21 patients and the last 20 patients. \u0000 \u0000 \u0000Results \u0000Mean total operative time was 324.9 mins (range 210-480) mins, and mean estimated blood loss was 177.6(range 50-700) ml. There were significant statistical differences in term of total operation time, construction time and blood loss between the first 21 patients and the next 20 patients (P<0.05). Postoperative pathological results were urothelial carcinoma in 40 cases (2 in situ carcinoma) and small cell carcinoma in 1 case. Mean number of dissected lymph nodes was 19 (range 11-58), with 7 cases(17.1%)of positive lymph nodes, and 3 cases(7.3%)had positive surgical margin. At a mean follow up of 17.6(range 2-64) months, 36 patients (87.8%) survived, including 2 patients (4.9%) with metastasis and 1 patient (2.4%) with recurrence, and 5 cases (12.2%)died. All patients were able to urinate without catheterization. Thirty-seven patients (90.2%) were satisfied with voiding control during the daytime (0-1 urinal pad), and 29 patients (70.7%) were satisfied with voiding control at nighttime (0-1 urinal pad) by the follow-up 12 months after the operation. \u0000 \u0000 \u0000Conclusions \u0000Total laparoscopic radical cystectomy combined with Xing's orthotopic ileum neobladder is a simple method with fewer postoperative complications and a satisfactory continence rate. \u0000 \u0000 \u0000Key words: \u0000Urin","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44069055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress in detection and clinical application of circulating tumor cells in renal cell carcinoma 循环肿瘤细胞在肾癌中的检测及临床应用进展
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.016
Xin Du, B. Hong, Qiang Zhao, Yongpeng Ji, Yong Yang, Ning Zhang
Renal cell carcinoma is one of the common malignant tumors in genitourinary cancer. 20%-30% of patients have distant metastases. However, current biomarkers used for diagnosis, recurrence monitoring, and prognosis assessment are still uncertain. Circulating tumor cells (CTCs) are tumor cells that are detached from the primary tumor or metastases, and invade and presenting in peripheral blood vessels. Therefore, CTCs is regarded as a key step in the process of tumor metastasis. However, current studies on CTCs of renal cell carcinoma are facing with problems such as inconsistent detection methods and limited clinical applications. This article reviews the progress in the detection and clinical application of CTCs of renal cell carcinoma. Key words: Carcinoma, renal cell; Circulating tumor cells (CTCs); Biomarker
肾细胞癌是泌尿生殖系统肿瘤中常见的恶性肿瘤之一。20%-30%的患者有远处转移。然而,目前用于诊断、复发监测和预后评估的生物标志物仍不确定。循环肿瘤细胞(CTCs)是从原发肿瘤或转移瘤中分离出来的肿瘤细胞,侵入并出现在外周血管中。因此,CTCs被认为是肿瘤转移过程中的关键步骤。然而,目前对肾癌ctc的研究存在检测方法不统一、临床应用受限等问题。本文就肾细胞癌CTCs的检测及临床应用进展作一综述。关键词:癌;肾细胞;循环肿瘤细胞(ctc);生物标志物
{"title":"Progress in detection and clinical application of circulating tumor cells in renal cell carcinoma","authors":"Xin Du, B. Hong, Qiang Zhao, Yongpeng Ji, Yong Yang, Ning Zhang","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.016","url":null,"abstract":"Renal cell carcinoma is one of the common malignant tumors in genitourinary cancer. 20%-30% of patients have distant metastases. However, current biomarkers used for diagnosis, recurrence monitoring, and prognosis assessment are still uncertain. Circulating tumor cells (CTCs) are tumor cells that are detached from the primary tumor or metastases, and invade and presenting in peripheral blood vessels. Therefore, CTCs is regarded as a key step in the process of tumor metastasis. However, current studies on CTCs of renal cell carcinoma are facing with problems such as inconsistent detection methods and limited clinical applications. This article reviews the progress in the detection and clinical application of CTCs of renal cell carcinoma. \u0000 \u0000Key words: \u0000Carcinoma, renal cell; Circulating tumor cells (CTCs); Biomarker","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42289638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of albumin-to-alkaline phosphatase ratio before radical cystectomy in patients with bladder cancer 膀胱癌根治性膀胱切除术前白蛋白与碱性磷酸酶比值的预后价值
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.005
Ming Zhao, Daqian Liu, X. Teng, Xiulong Zhong, Yonghua Wang, Haitao Niu, Xin-sheng Wang
Objective To investigate the relationship between preoperative albumin-to-alkaline phosphatase ratio and overall survival (OS) after radical cystectomy of bladder cancer. Methods The clinical date of patients with bladder cancer who underwent radical cystectomy and urinary diversion and confirmed by pathology from Jan 2007 to Dec 2015 were analyzed retrospectively, with 140 cases undergoing laparoscopic surgery and 26 cases undergoing open surgery. There were 148 males and 18 females, aged was 33-85 years, with an average age of (65.1±9.4) years. There were 55 cases of cutaneous ureterostomy, 96 cases of Brick diversion with ileum, and 15 cases of ileal neobladder. The AAPR range 0.03-1.67, with an average 0.62±0.23, and body mass index (BMI) was 16.79-32.65 kg/m2, with an average of (24.00±3.32) kg/m2. There were 33 cases with hydronephrosis and 133 no hydronephrosis, 31 cases with hypertension and 135 cases no hypertension, and 14 cases with diabetes and 152 cases no diabetes. Four cases were classified as grade 0, 65 cases as grade 1, 86 cases as grade 2, and 11 cases as grade 3. Based on the preoperative AAPR(0.62±0.23), they were divided into three groups, with 55 cases in the low AAPR (0.42±0.09)group, 55 cases in the middle AAPR(0.58±0.05)group, and 56 cases in the high AAPR(0.86±0.21)group. Cox proportional hazards regression methodology were used to evaluate the relationship between preoperative AAPR and overall survival. Survival analysis was conducted using the Kaplan-Meier method and compared with the log-rank test. Results 166 patients were followed up for 1-144 months, with a median of 63 months, and 71 cases died and 95 survived. The median serum AAPR level in all cases was 0.59(range 0.03-1.67). Results of univariate Cox regression model revealed that AAPR(HR=0.09, 95%CI 0.022-0.391, P=0.001), high AAPR (HR=0.40, 95%CI 0.216-0.742, P=0.003), age (HR=2.42, 95%CI 1.294-4.531, P=0.006), tumor size (HR=2.11, 95%CI 1.112-4.014, P=0.023), pT3 stage (HR=8.93, 95%CI 3.173-25.114, P<0.001), pT4 stage(HR=10.39, 95%CI 3.110-34.707, P<0.001), pN1 stage(HR=2.80, 95%CI 1.422-5.531, P=0.003), pN3 stage(HR=17.06, 95%CI 2.192-132.863, P=0.007), pathological grade (HR=0.30, 95%CI 0.113-0.817, P=0.019), hydronephrosis (HR=2.36, 95%CI 1.406-3.939, P=0.001), adjuvant chemotherapy (HR=2.66, 95%CI 1.674-4.247, P<0.001)were associated with OS. Compared with patients in the lowest of AAPR, the risk for death in the highest AAPR group decreased about 59%(HR=0.406, 95%CI 0.200-0.822, P=0.012)after adjustment for age, BMI, tumor size, number of tumor, T category, N category, pathological grade, hydronephrosis, ASA level, adjuvant chemotherapy in multiple Cox regression models. Each unit increase in the AAPR was associated with about 80% decreased risk of death (HR=0.199, 95%CI 0.051-0.779, P=0.020)after adjusting for the confounding variables. After adjusting for age, BMI, tumor size, number of tumor, T category, N category, pathological grade,
目的探讨癌症膀胱切除术前白蛋白与碱性磷酸酶比值与总生存率的关系。方法回顾性分析2007年1月至2015年12月经病理证实的癌症患者行根治性膀胱切除术和尿路转移术的临床资料,其中腹腔镜手术140例,开放手术26例。男148例,女18例,年龄33~85岁,平均年龄(65.1±9.4)岁。其中皮肤输尿管造瘘55例,回肠Brick引流96例,回肠新膀胱造瘘15例。AAPR范围为0.03-1.67,平均0.62±0.23,体重指数(BMI)为16.79-32.65 kg/m2,平均(24.00±3.32)kg/m2。肾积水33例,无积水133例,高血压31例,无高血压135例,糖尿病14例,无糖尿病152例。4例为0级,65例为1级,86例为2级,11例为3级。根据术前AAPR(0.62±0.23)分为三组,低AAPR组55例(0.42±0.09),中AAPR组5例(0.58±0.05),高AAPR组56例(0.86±0.21)。使用Kaplan-Meier方法进行生存分析,并与对数秩检验进行比较。结果166例患者随访1-144个月,中位随访63个月,死亡71例,存活95例。所有病例的中位血清AAPR水平为0.59(范围0.03-1.67)。单变量Cox回归模型结果显示,AAPR(HR=0.09,95%CI 0.022-0.391,P=0.001)、高AAPR(HR=0.40,95%CI 0.216-0.742,P=0.003)、年龄(HR=2.42,95%CI 1.294-4.531,P=0.006)、肿瘤大小(HR=2.11,95%CI 1.112-4.04,P=0.023)、pT3分期(HR=8.93,95%CI 3.173-25.114,P<0.001),pT4期(HR=10.39,95%CI 3.110-34.707,P=0.001)、pN1期(HR=2.80,95%CI 1.422-5.531,P=0.003)、pN3期(HR=17.06,95%CI 2.192-132.863,P=0.007)、病理分级(HR=0.30,95%CI 0.113-0.817,P=0.019)、肾积水(HR=2.36,95%CI 1.406-3.939,P=0.001。与AAPR最低的患者相比,在多重Cox回归模型中调整了年龄、BMI、肿瘤大小、肿瘤数量、T类、N类、病理分级、肾积水、ASA水平、辅助化疗后,AAPR最高组的死亡风险降低了约59%(HR=0.406,95%CI 0.200-0.822,P=0.012)。调整混杂变量后,AAPR的每单位增加与死亡风险降低约80%有关(HR=0.199,95%CI 0.051-0.779,P=0.020)。在校正年龄、BMI、肿瘤大小、肿瘤数量、T类、N类、病理分级、肾积水、ASA水平、辅助化疗后,曲线拟合结果显示,随着AAPR的增加,死亡风险降低,总生存期延长。与线性趋势测试结果一致,AAPR和OS之间的关系是线性的。结论AAPR与癌症全膀胱切除术患者的总生存率有关。关键词:膀胱肿瘤;癌症;白蛋白与碱性磷酸酶比值(AAPR);根治性膀胱切除术;预后
{"title":"Prognostic value of albumin-to-alkaline phosphatase ratio before radical cystectomy in patients with bladder cancer","authors":"Ming Zhao, Daqian Liu, X. Teng, Xiulong Zhong, Yonghua Wang, Haitao Niu, Xin-sheng Wang","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.005","url":null,"abstract":"Objective \u0000To investigate the relationship between preoperative albumin-to-alkaline phosphatase ratio and overall survival (OS) after radical cystectomy of bladder cancer. \u0000 \u0000 \u0000Methods \u0000The clinical date of patients with bladder cancer who underwent radical cystectomy and urinary diversion and confirmed by pathology from Jan 2007 to Dec 2015 were analyzed retrospectively, with 140 cases undergoing laparoscopic surgery and 26 cases undergoing open surgery. There were 148 males and 18 females, aged was 33-85 years, with an average age of (65.1±9.4) years. There were 55 cases of cutaneous ureterostomy, 96 cases of Brick diversion with ileum, and 15 cases of ileal neobladder. The AAPR range 0.03-1.67, with an average 0.62±0.23, and body mass index (BMI) was 16.79-32.65 kg/m2, with an average of (24.00±3.32) kg/m2. There were 33 cases with hydronephrosis and 133 no hydronephrosis, 31 cases with hypertension and 135 cases no hypertension, and 14 cases with diabetes and 152 cases no diabetes. Four cases were classified as grade 0, 65 cases as grade 1, 86 cases as grade 2, and 11 cases as grade 3. Based on the preoperative AAPR(0.62±0.23), they were divided into three groups, with 55 cases in the low AAPR (0.42±0.09)group, 55 cases in the middle AAPR(0.58±0.05)group, and 56 cases in the high AAPR(0.86±0.21)group. Cox proportional hazards regression methodology were used to evaluate the relationship between preoperative AAPR and overall survival. Survival analysis was conducted using the Kaplan-Meier method and compared with the log-rank test. \u0000 \u0000 \u0000Results \u0000166 patients were followed up for 1-144 months, with a median of 63 months, and 71 cases died and 95 survived. The median serum AAPR level in all cases was 0.59(range 0.03-1.67). Results of univariate Cox regression model revealed that AAPR(HR=0.09, 95%CI 0.022-0.391, P=0.001), high AAPR (HR=0.40, 95%CI 0.216-0.742, P=0.003), age (HR=2.42, 95%CI 1.294-4.531, P=0.006), tumor size (HR=2.11, 95%CI 1.112-4.014, P=0.023), pT3 stage (HR=8.93, 95%CI 3.173-25.114, P<0.001), pT4 stage(HR=10.39, 95%CI 3.110-34.707, P<0.001), pN1 stage(HR=2.80, 95%CI 1.422-5.531, P=0.003), pN3 stage(HR=17.06, 95%CI 2.192-132.863, P=0.007), pathological grade (HR=0.30, 95%CI 0.113-0.817, P=0.019), hydronephrosis (HR=2.36, 95%CI 1.406-3.939, P=0.001), adjuvant chemotherapy (HR=2.66, 95%CI 1.674-4.247, P<0.001)were associated with OS. Compared with patients in the lowest of AAPR, the risk for death in the highest AAPR group decreased about 59%(HR=0.406, 95%CI 0.200-0.822, P=0.012)after adjustment for age, BMI, tumor size, number of tumor, T category, N category, pathological grade, hydronephrosis, ASA level, adjuvant chemotherapy in multiple Cox regression models. Each unit increase in the AAPR was associated with about 80% decreased risk of death (HR=0.199, 95%CI 0.051-0.779, P=0.020)after adjusting for the confounding variables. After adjusting for age, BMI, tumor size, number of tumor, T category, N category, pathological grade, ","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44231496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accelerating the development of Chinese urology in clinical research by taking the advantages and making cooperation 发挥优势,开展合作,加快我国泌尿外科临床研究的发展
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.001
Jian Huang
The clinical research is an important cornerstone of medical innovation and development. In the past decade, there have been some breakthrough achievements in the field of urological clinical research internationally. However, there is still a large gap between Chinese urological clinical research and the international level. Urologists across China should improve the clinical research to a new level of awareness, starting with the idea of patients’expectation being our concern, and making clinical research our priority. The multi-center clinical research should be the priority, involving the real-world study, prospective randomized controlled trails, translational medicine, and artificial intelligence, etc. The standardized method must be adopted and the integrity of scientific research should be concerned in the process of clinical research. The clinical research results should not only be published in the international journals, but more importantly be published in the domestic journals. The proposal of "publishing the studies on the land of our motherland" should be vigorously advocated. Key words: Clinical research; Multicenter; Real-world study; Prospective randomized contro-lled trails; Translational medicine; Artificial intelligence; Research integrity
临床研究是医学创新与发展的重要基石。在过去的十年里,国际上在泌尿外科临床研究领域取得了一些突破性的成果。然而,我国泌尿外科临床研究与国际水平仍有较大差距。中国各地的泌尿科医生应该将临床研究提高到一个新的水平,从患者的期望是我们关注的想法开始,并将临床研究作为我们的优先事项。应优先开展多中心临床研究,包括真实世界研究、前瞻性随机对照试验、转化医学和人工智能等。在临床研究过程中,必须采用标准化的方法,并关注科学研究的完整性。临床研究成果不仅要在国际期刊上发表,更重要的是要在国内期刊上发表。要大力提倡“出版关于祖国土地的研究”。关键词:临床研究;多中心;现实世界研究;前瞻性随机对照试验;转化医学;人工智能;研究诚信
{"title":"Accelerating the development of Chinese urology in clinical research by taking the advantages and making cooperation","authors":"Jian Huang","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.001","url":null,"abstract":"The clinical research is an important cornerstone of medical innovation and development. In the past decade, there have been some breakthrough achievements in the field of urological clinical research internationally. However, there is still a large gap between Chinese urological clinical research and the international level. Urologists across China should improve the clinical research to a new level of awareness, starting with the idea of patients’expectation being our concern, and making clinical research our priority. The multi-center clinical research should be the priority, involving the real-world study, prospective randomized controlled trails, translational medicine, and artificial intelligence, etc. The standardized method must be adopted and the integrity of scientific research should be concerned in the process of clinical research. The clinical research results should not only be published in the international journals, but more importantly be published in the domestic journals. The proposal of \"publishing the studies on the land of our motherland\" should be vigorously advocated. \u0000 \u0000Key words: \u0000Clinical research; Multicenter; Real-world study; Prospective randomized contro-lled trails; Translational medicine; Artificial intelligence; Research integrity","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47900397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case report of duplex kidney and ureter abnormality accompanied with lower giant hydronephrosis 双肾输尿管畸形伴下巨大肾积水1例报告
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.012
Tao Yang, Hong Xie, Xiaoyong Hu, Jianwen Huang
Duplex kidney and ureter abnormality are one of the most common malformation in urinary system, with most of patients present no apparent symptom, and only a few patients being complicated by ureter obstruction and serious hydronephrosis, which is difficult to differentiate with renal cyst. Therefore a case with duplex kidney and ureter abnormality was reported to provide information for clinical practice. Key words: Ureteral disease; Duplex kidney and ureter abnormality; Hydronephrosis
双肾和输尿管畸形是泌尿系统最常见的畸形之一,大多数患者没有明显症状,只有少数患者并发输尿管梗阻和严重积水,难以与肾囊肿鉴别。因此,报告了一例双肾输尿管异常,为临床实践提供信息。关键词:输尿管疾病;双肾和输尿管异常;肾积水
{"title":"A case report of duplex kidney and ureter abnormality accompanied with lower giant hydronephrosis","authors":"Tao Yang, Hong Xie, Xiaoyong Hu, Jianwen Huang","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.012","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.012","url":null,"abstract":"Duplex kidney and ureter abnormality are one of the most common malformation in urinary system, with most of patients present no apparent symptom, and only a few patients being complicated by ureter obstruction and serious hydronephrosis, which is difficult to differentiate with renal cyst. Therefore a case with duplex kidney and ureter abnormality was reported to provide information for clinical practice. \u0000 \u0000Key words: \u0000Ureteral disease; Duplex kidney and ureter abnormality; Hydronephrosis","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42431562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case report of spermatic neuroblastoma 精索神经母细胞瘤1例报告
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.015
Jian-xiang Xie, Jia-xi Li, C. Du
The purpose of this study is to study the clinical characteristics of spermatic cord tumor. The clinical data of a case of varicocele in our hospital were analyzed retrospectively. In this case, the patients with varicocele had a good recovery after operation. Varicocele is a rare case. The best mode of treatment is surgical resection and follow-up after operation. Key words: Spermatic cord; Spermatic schwannoma; Benign mass
本研究旨在探讨精索肿瘤的临床特点。对我院收治的1例精索静脉曲张的临床资料进行回顾性分析。本例精索静脉曲张患者术后恢复良好。精索静脉曲张是一种罕见的病例。最好的治疗方式是手术切除,术后随访。关键词:精索;精索神经鞘瘤;良性的质量
{"title":"A case report of spermatic neuroblastoma","authors":"Jian-xiang Xie, Jia-xi Li, C. Du","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.015","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.015","url":null,"abstract":"The purpose of this study is to study the clinical characteristics of spermatic cord tumor. The clinical data of a case of varicocele in our hospital were analyzed retrospectively. In this case, the patients with varicocele had a good recovery after operation. Varicocele is a rare case. The best mode of treatment is surgical resection and follow-up after operation. \u0000 \u0000Key words: \u0000Spermatic cord; Spermatic schwannoma; Benign mass","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48864171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The application and outcomes of C. R.P.C. four-step radical prostatectomy under extraperitoneal laparoscopy 腹膜外腹腔镜下C.R.P.C.四步前列腺根治术的应用及效果
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.006
Jun Xiao, Gan Yu, Huixia Zhou, Henglong Hu, Xueyou Ma, Yanan Wang, Chunguang Yang, Zhiquan Hu, Shaogang Wang, Z. Ye, Zhihua Wang
Objective To summarize the preliminary experience of extraperitoneal laparoscopic radical prostatectomy (C.R.P.C. four-step) for localized prostate cancer and the outcomes based on early follow-up. Methods A total of 102 prostate cancer patients were screened by prostate specific antigen (PSA) and diagnosed by prostate magnetic resonance imaging and prostatic puncture biopsy with cT1c-cT3b, with average age of (67±5) years old, average preoperative total PSA value of (45.32±18.33) ng/ml, and average prostate volume was (42±12)cm3. All these patients underwent extraperitoneal laparoscopic radical prostatectomy by the four-step technique, abbreviating as C. R.P.C.[C: control DVC (dorsal deep venous complex). R: recognize three anatomical layers (prostate and bladder junction, seminal vesicle, and Denonvilliers’fascia surface). P: preserve urethral sphincter and bladder neck. C: continuous anastomosis between urethra and bladder neck (4 key needles at 3, 5, 7 and 9 o’clock)]. The operative time, estimated blood loss, length of hospital stay and postoperative complications were recorded, and the postoperative PSA was followed up. Results All the 102 cases were successfully treated by laparoscopic radical prostatectomy. The operative time was from 55 to 156 min (mean 92 min), and the estimated blood loss was from 55 to 185 ml (mean 105 ml). There was no case converted of open surgery, only one case received blood transfusion for postoperative hemorrhage (0.98%), and positive surgical margin was found in 15 case (14.70%) by pathological examination. Postoperative urinary extravasation within one week occurred in 2 (1.96%) cases, and resolved after tensioning the catheter and prolonging the indwelling time. During the follow-up period of 12 to 45 months, 2 cases were incontinent (grade Ⅰ-Ⅱ), and the other cases(98.04%) had no incontinence or dysuria . However, 11 cases(10.78%) developed to biochemical recurrence within 6 months after the operation. Conclusions The C. R.P.C. four-step technique of lparoscopic radical prostatectomy is easily to be grasped and performed by the greenhand urologists, and was efficient and safe. Key words: Prostatic neoplasms; Radical prostatectomy; Extraperitoneal laparoscopy; Prostate cancer; Four-step method; Curative effect
目的总结腹腔镜下四步根治性前列腺切除术治疗局限性前列腺癌的初步经验及早期随访的效果。方法对102例前列腺癌患者进行前列腺特异抗原(PSA)筛查,经前列腺磁共振成像和前列腺穿刺活检诊断,检测结果为cT1c-cT3b,平均年龄(67±5)岁,平均术前总PSA值(45.32±18.33)ng/ml,平均前列腺体积(42±12)cm3。所有患者均行腹腔外腹腔镜根治性前列腺切除术,采用四步技术,简称为c.r.p.c. [C: control DVC (dorsal deep venous complex)]。R:识别三个解剖层(前列腺与膀胱交界处、精囊、德农维利氏筋膜表面)。保尿道括约肌及膀胱颈。C:尿道与膀胱颈间连续吻合(3、5、7、9点钟方向4根键针)。记录手术时间、预计出血量、住院时间及术后并发症,并随访术后PSA。结果102例患者均成功行腹腔镜根治性前列腺切除术。手术时间55 ~ 156 min(平均92 min),估计失血量55 ~ 185 ml(平均105 ml)。无中转开腹手术,术后出血输血1例(0.98%),病理检查手术切缘阳性15例(14.70%)。术后1周内发生尿外渗2例(1.96%),经拉紧导尿管并延长留置时间后,尿外渗得以缓解。随访12 ~ 45个月,2例出现尿失禁(级别Ⅰ~Ⅱ),其余98.04%无尿失禁或排尿困难。术后6个月内生化复发11例(10.78%)。结论腹腔镜根治性前列腺切除术的四步法易于泌尿外科新手掌握和操作,安全有效。关键词:前列腺肿瘤;根治性前列腺切除术;Extraperitoneal腹腔镜检查;前列腺癌;四个步骤的方法;疗效
{"title":"The application and outcomes of C. R.P.C. four-step radical prostatectomy under extraperitoneal laparoscopy","authors":"Jun Xiao, Gan Yu, Huixia Zhou, Henglong Hu, Xueyou Ma, Yanan Wang, Chunguang Yang, Zhiquan Hu, Shaogang Wang, Z. Ye, Zhihua Wang","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.006","url":null,"abstract":"Objective \u0000To summarize the preliminary experience of extraperitoneal laparoscopic radical prostatectomy (C.R.P.C. four-step) for localized prostate cancer and the outcomes based on early follow-up. \u0000 \u0000 \u0000Methods \u0000A total of 102 prostate cancer patients were screened by prostate specific antigen (PSA) and diagnosed by prostate magnetic resonance imaging and prostatic puncture biopsy with cT1c-cT3b, with average age of (67±5) years old, average preoperative total PSA value of (45.32±18.33) ng/ml, and average prostate volume was (42±12)cm3. All these patients underwent extraperitoneal laparoscopic radical prostatectomy by the four-step technique, abbreviating as C. R.P.C.[C: control DVC (dorsal deep venous complex). R: recognize three anatomical layers (prostate and bladder junction, seminal vesicle, and Denonvilliers’fascia surface). P: preserve urethral sphincter and bladder neck. C: continuous anastomosis between urethra and bladder neck (4 key needles at 3, 5, 7 and 9 o’clock)]. The operative time, estimated blood loss, length of hospital stay and postoperative complications were recorded, and the postoperative PSA was followed up. \u0000 \u0000 \u0000Results \u0000All the 102 cases were successfully treated by laparoscopic radical prostatectomy. The operative time was from 55 to 156 min (mean 92 min), and the estimated blood loss was from 55 to 185 ml (mean 105 ml). There was no case converted of open surgery, only one case received blood transfusion for postoperative hemorrhage (0.98%), and positive surgical margin was found in 15 case (14.70%) by pathological examination. Postoperative urinary extravasation within one week occurred in 2 (1.96%) cases, and resolved after tensioning the catheter and prolonging the indwelling time. During the follow-up period of 12 to 45 months, 2 cases were incontinent (grade Ⅰ-Ⅱ), and the other cases(98.04%) had no incontinence or dysuria . However, 11 cases(10.78%) developed to biochemical recurrence within 6 months after the operation. \u0000 \u0000 \u0000Conclusions \u0000The C. R.P.C. four-step technique of lparoscopic radical prostatectomy is easily to be grasped and performed by the greenhand urologists, and was efficient and safe. \u0000 \u0000 \u0000Key words: \u0000Prostatic neoplasms; Radical prostatectomy; Extraperitoneal laparoscopy; Prostate cancer; Four-step method; Curative effect","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45407050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of endocrine therapy on lipid metabolism and nutritional status in elderly patients with prostate cancer 内分泌治疗对老年癌症患者脂质代谢及营养状况的影响
Q4 Medicine Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1000-6702.2020.02.009
Zijian Tian, H. Hou, S. Lai, Shengjie Liu, Xingbo Long, Miao Wang, Jianye Wang, Ming Liu
Objective To analyze effects of androgen deprivation therapy on lipid metabolism and nutritional status in patients with prostate cancer. Methods The clinical data of 255 elderly patients (≥ 65 years old) with prostate cancer who received endocrine therapy and complete follow-up data from January 2010 to December 2018 were analyzed retrospectively. The median age of the 255 patients was 76 years(65-92). The average PSA of patients was (58.15±9.62) ng/ml, where 101 patients had PSA 20 ng/ml. All patients were diagnosed pathologically by prostate biopsy. As for Gleason score, Gleason score≤6, Gleason score=7 and Gleason score≥ 8 had 62, 103 and 90 patients, respectively. Endocrine therapy included maximum androgen blockade (197 cases) and drug castration (58 cases), and continued for at least 1 year. Among them, 123 cases had complete blood lipid index data, and the subgroup analysis was based on the age of 80 years old, including 98 cases aged 65 to 80 years old and 25 cases over 80 years old. A total of 186 cases had complete data of total protein and albumin, of which 147 cases were 65 years old and 80 years old and 39 cases were more than 80 years old. Before treatment, cholesterol was (4.08±0.87)mmol/L, including (4.14±0.86) mmol/L in the 65-80 years old group, (3.82±0.88) mmol/L in >80 years old group; triglyceride was (1.23 ±0.56) mmol/L, 65-80 age group was (1.26±0.56) mmol/L and >80 years old group was (1.11±0.57) mmol/L; High density lipoprotein cholesterol was(1.09±0.24)mmol/L, 65-80 age group was (1.10±0.25) mmol/L and >80 years group was (1.04±0.21) mmol/L. Low density lipoprotein cholesterol was (2.50±0.78)mmol/L, 65~80 age group was (2.55±0.77)mmol/L and (2.34±0.83) mmol/L in >80 years old group.The total protein before endocrine therapy was (63.81±5.93) g/L, including (63.95±5.79) g/L in the 65-80 years old group, (63.30±6.49) g/L in >80 years old group. In terms of pre-treatment albumin (39.68±3.50) g/L, including (39.82±3.60) g/L in the 65-80 years old group and (39.21±3.12) g/L in >80 years old group. The differences of various indexes before and after treatment were analyzed. Results The results of blood lipid data analysis of 123 cases showed that, there were increased significant differences(P 0.05). The results of data analysis of 186 cases of total protein and albumin showed that, the total protein after treatment was (62.81±7.34) g/L, which was not significantly different from that before treatment (P>0.05). The total protein in 65-80 years old group after treatment was (62.36±7.36) g/L, which decrease and have statistical significantly different from that before treatment (P 80 years old group after treatment was (64.49±7.12) g/L, it was higher than that before treatment, but the difference was not statistically significant (P>0.05). The level of albumin after endocrine therapy was (38.34±4.48) g/L, which was significantly different from that before treatment (P 80 years old group after treatment were (38.32±4
目的分析雄激素剥夺治疗对前列腺癌症患者脂代谢及营养状况的影响。方法回顾性分析2010年1月至2018年12月255例老年(≥65岁)癌症前列腺癌患者接受内分泌治疗的临床资料和完整的随访资料。255名患者的中位年龄为76岁(65-92岁)。患者的平均PSA为(58.15±9.62)ng/ml,其中101例患者的PSA为20 ng/ml。所有患者均经前列腺活检病理诊断。在Gleason评分方面,Gleason分≤6、Gleason得分=7和Gleason分数≥8的患者分别为62例、103例和90例。内分泌治疗包括最大雄激素阻断(197例)和药物阉割(58例),并持续至少1年。其中,123例血脂指标数据完整,亚组分析以80岁为年龄段,其中65~80岁98例,80岁以上25例。186例患者的总蛋白和白蛋白数据完整,其中147例为65岁和80岁,39例为80岁以上。治疗前胆固醇为(4.08±0.87)mmol/L,其中65-80岁组胆固醇为(4.14±0.86)mmol/L;>80岁组为(3.82±0.88)mmol/L;甘油三酯为(1.23±0.56)mmol/L,65-80岁组为(1.26±0.56”mmol/L,80岁以上组为(1.11±0.57)mmol/L;高密度脂蛋白胆固醇为(1.09±0.24)mmol/L,65-80岁年龄组为(1.10±0.25)mmol/L;>80岁组为(1.04±0.21)mmol/L。低密度脂蛋白胆固醇为(2.50±0.78)mmol/L,65~80岁组为(2.55±0.77)mmol/L;80岁以上组为(2.34±0.83)mmol/L。内分泌治疗前总蛋白为(63.81±5.93)g/L,其中65-80岁组为(63.95±5.79)g/L,>80岁组(63.30±6.49)g/L。治疗前白蛋白(39.68±3.50)g/L,其中65-80岁组为(39.82±3.60)g/L;>80岁组则为(39.21±3.12)g/L。分析治疗前后各项指标的差异。结果对123例患者的血脂数据分析结果显示,有显著性差异(P<0.05),对186例患者的总蛋白和白蛋白数据分析结果表明:治疗后总蛋白为(62.81±7.34)g/L,65-80岁组治疗后总蛋白为(62.36±7.36)g/L,与治疗前相比有统计学意义(P<0.05),内分泌治疗后白蛋白水平为(38.34±4.48)g/L,与治疗前有显著性差异(P 80岁组治疗后分别为(38.32±4.54)g/L和(38.44±4.30)g/L,仅65~80岁组,结论内分泌治疗不仅能显著提高老年前列腺癌症患者的总胆固醇、甘油三酯、低密度脂蛋白胆固醇和高密度脂蛋白蛋白胆固醇,而且能显著降低治疗后的白蛋白。关键词:前列腺癌症;内分泌治疗;脂质代谢;营养状况
{"title":"Effects of endocrine therapy on lipid metabolism and nutritional status in elderly patients with prostate cancer","authors":"Zijian Tian, H. Hou, S. Lai, Shengjie Liu, Xingbo Long, Miao Wang, Jianye Wang, Ming Liu","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.02.009","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.02.009","url":null,"abstract":"Objective \u0000To analyze effects of androgen deprivation therapy on lipid metabolism and nutritional status in patients with prostate cancer. \u0000 \u0000 \u0000Methods \u0000The clinical data of 255 elderly patients (≥ 65 years old) with prostate cancer who received endocrine therapy and complete follow-up data from January 2010 to December 2018 were analyzed retrospectively. The median age of the 255 patients was 76 years(65-92). The average PSA of patients was (58.15±9.62) ng/ml, where 101 patients had PSA 20 ng/ml. All patients were diagnosed pathologically by prostate biopsy. As for Gleason score, Gleason score≤6, Gleason score=7 and Gleason score≥ 8 had 62, 103 and 90 patients, respectively. Endocrine therapy included maximum androgen blockade (197 cases) and drug castration (58 cases), and continued for at least 1 year. Among them, 123 cases had complete blood lipid index data, and the subgroup analysis was based on the age of 80 years old, including 98 cases aged 65 to 80 years old and 25 cases over 80 years old. A total of 186 cases had complete data of total protein and albumin, of which 147 cases were 65 years old and 80 years old and 39 cases were more than 80 years old. Before treatment, cholesterol was (4.08±0.87)mmol/L, including (4.14±0.86) mmol/L in the 65-80 years old group, (3.82±0.88) mmol/L in >80 years old group; triglyceride was (1.23 ±0.56) mmol/L, 65-80 age group was (1.26±0.56) mmol/L and >80 years old group was (1.11±0.57) mmol/L; High density lipoprotein cholesterol was(1.09±0.24)mmol/L, 65-80 age group was (1.10±0.25) mmol/L and >80 years group was (1.04±0.21) mmol/L. Low density lipoprotein cholesterol was (2.50±0.78)mmol/L, 65~80 age group was (2.55±0.77)mmol/L and (2.34±0.83) mmol/L in >80 years old group.The total protein before endocrine therapy was (63.81±5.93) g/L, including (63.95±5.79) g/L in the 65-80 years old group, (63.30±6.49) g/L in >80 years old group. In terms of pre-treatment albumin (39.68±3.50) g/L, including (39.82±3.60) g/L in the 65-80 years old group and (39.21±3.12) g/L in >80 years old group. The differences of various indexes before and after treatment were analyzed. \u0000 \u0000 \u0000Results \u0000The results of blood lipid data analysis of 123 cases showed that, there were increased significant differences(P 0.05). The results of data analysis of 186 cases of total protein and albumin showed that, the total protein after treatment was (62.81±7.34) g/L, which was not significantly different from that before treatment (P>0.05). The total protein in 65-80 years old group after treatment was (62.36±7.36) g/L, which decrease and have statistical significantly different from that before treatment (P 80 years old group after treatment was (64.49±7.12) g/L, it was higher than that before treatment, but the difference was not statistically significant (P>0.05). The level of albumin after endocrine therapy was (38.34±4.48) g/L, which was significantly different from that before treatment (P 80 years old group after treatment were (38.32±4","PeriodicalId":10343,"journal":{"name":"Chinese Journal of Urology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42770213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华泌尿外科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1